CD Biosynsis offers comprehensive Corynebacterium glutamicum Pathway Optimization Services, focusing on advanced metabolic engineering and synthetic biology to enhance the productivity of this crucial industrial host. Our goal is to systematically maximize the titer, yield, and production rate of target compounds (e.g., amino acids, fine chemicals) by rationally redesigning and balancing the host's central metabolic network. We integrate cutting-edge tools, including CRISPR-Cas9 precision editing and predictive modeling, to minimize trial-and-error and deliver high-performance, commercially viable strains ready for scale-up.
Get a QuoteOptimizing C. glutamicum pathways is crucial for achieving high-yield, cost-effective industrial bioproduction, particularly for amino acids. Our strategic approach involves identifying and overcoming systemic bottlenecks, which often stem from inefficient enzyme kinetics, product feedback inhibition, or competing metabolic routes. We apply systematic pathway redesign to precisely control carbon flux, enhance precursor supply, and ensure optimal enzyme stoichiometry. By providing a truly rational design based on quantitative data and predictive models, we transform your C. glutamicum host into a high-efficiency metabolic powerhouse ready for commercial scale-up.
Upstream Enzyme Overexpression
Increasing the expression of rate-limiting enzymes in central carbon metabolism to funnel more substrate toward the desired pathway intermediate.
Feedback Inhibition Relief
Introducing specific point mutations via Base Editing to eliminate native allosteric feedback inhibition on key regulatory enzymes, ensuring constitutive activity.
Gene Knock-in for Amplification
Stable chromosomal integration of additional gene copies under strong promoters to permanently enhance the activity of crucial pathway steps.
Gene Knockout (Permanent Block)
Precise, marker-free CRISPR-Cas9 Gene Knockout of genes responsible for creating unwanted byproducts (e.g., lactate, acetate) or energy sinks.
CRISPRi Downregulation (Tunable Block)
Using CRISPR Interference (CRISPRi) for tunable, reversible repression of competing pathways, useful for optimizing flux where complete knockout is detrimental.
Multi-Gene Knockout
Simultaneous or sequential inactivation of multiple redundant genes or competing pathways to ensure all carbon flux is channeled to the target product.
Promoter & RBS Engineering
Designing and integrating a gradient library of promoters and Ribosomal Binding Sites (RBS) to precisely tune and balance the expression level of pathway enzymes.
Transporter Optimization
Engineering or overexpressing product export transporters to accelerate the release of the final product, relieving intracellular product inhibition.
Heterologous Pathway Integration
Stable chromosomal Knock-in of multi-gene biosynthetic pathways for producing non-native compounds with optimal, balanced expression.
We utilize the integrated Design-Build-Test-Learn (DBTL) cycle for rapid, data-driven strain improvement.
1. Design (Modeling & Targets)
2. Build (Precision Editing)
3. Test (Assay & Quantification)
4. Learn (Refinement & Scale-Up)
Computational modeling (FBA or Kinetic Analysis) to simulate flux and predict bottlenecks.
Rational identification of the most impactful genetic targets (Knockout, Base Edit, Knock-in).
Design of precision editing strategies and donor templates.
Execution of CRISPR-Cas9 Gene Editing for large modifications.
Utilization of Base Editing for single-base precision and regulatory tuning.
Construction and integration of optimized expression cassettes.
Integration of quantitative assay data to validate and refine the computational model.
Recommendation of the next, refined genetic iteration (Learn).
Final strain validation for stability and scale-up performance.
Predictive Metabolic Modeling
All genetic edits are guided by FBA and Kinetic Modeling to maximize predictability and reduce costly empirical testing.
Integrated Editing Toolkit
Combines CRISPR-Cas9, Base Editing, and CRISPRi to perform knockout, point mutation, and reversible repression seamlessly.
Precision Enzyme Tuning
Use of Base Editing for DSB-free single nucleotide substitutions, perfect for optimizing enzyme active sites or allosteric sites.
Quantitative Flux Validation
Rely on rigorous Metabolomics (HPLC/GC-MS) and Fluxomics ($^{13}\text{C}$ tracing) to verify the actual shift in metabolic flux.
"The combination of their FBA modeling and CRISPR-Cas9 knockouts perfectly redirected our carbon flux. We achieved a 35% increase in product yield with minimal byproduct formation."
Dr. Chen, Head of Strain Engineering, Industrial Amino Acid Producer
"Using Base Editing to eliminate feedback inhibition on a key regulatory enzyme was a game-changer. The optimized C. glutamicum strain showed constitutive high-rate production."
Mr. David Smith, Project Manager, Metabolic Pathway Optimization Group
"The quantitative HPLC data confirmed that the pathway balancing achieved through Promoter/RBS engineering led to the lowest accumulation of toxic intermediates we've ever seen."
Dr. Lena Koo, R&D Scientist, Synthetic Biology Startup
"The integrated approach is highly efficient. They managed the entire DBTL cycle, resulting in a robust, stable strain ready for large-scale fermentation trials in a record timeframe."
Dr. Alan Rivas, Lab Director, Applied Microbiology Institute
What is the role of modeling (FBA/Kinetic) in the optimization service?
Modeling provides the rational foundation. FBA predicts theoretical maximum yields, and Kinetic Modeling simulates dynamic behavior, allowing us to select the most effective genetic targets before any lab work begins.
How does the service handle competing metabolic pathways?
We use CRISPR-Cas9 Knockout for permanent elimination of major competitors, and CRISPRi for the tunable downregulation of pathways where partial activity is still necessary.
Can you integrate an entirely new (heterologous) pathway?
Yes. We use Gene Knock-in services for the stable chromosomal integration of multi-gene biosynthetic pathways, followed by balancing and optimization of the expression levels for each component.
What kind of data confirms successful pathway optimization?
Success is confirmed by quantitative phenotypic data, including increased final titer, enhanced volumetric productivity, reduced byproduct accumulation, and verified genetic stability.
What is the benefit of using Base Editing for pathway optimization?
Base Editing allows for the DSB-free, precise mutation of regulatory or active sites, providing a non-lethal way to eliminate feedback inhibition or fine-tune enzyme kinetics.
Do you offer optimization for product export?
Yes. Optimizing export transporters (via Knock-in or overexpression) is a key strategy to relieve intracellular product inhibition and maximize the overall yield and synthesis rate.
How is the stability of the optimized strain verified?
We verify stability by prioritizing chromosomal integration and conducting rigorous in vivo genetic stability tests (long-term passage) under non-selective conditions.
What fermentation conditions can you optimize for?
We optimize pathways for performance under various conditions, including fed-batch, continuous culture, different carbon/nitrogen sources, and specific pH or temperature ranges relevant to industrial scale-up.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.